Company / SG&A per Share
Jade Biosciences, Inc. SG&A per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.75
FY2024
5-year range
$0.60 / $3.92
FY2020-FY2024
Trend
+14.7%
vs FY2023
Sector context
#142 of 206
Health Care
What the data says
At $0.75, Jade Biosciences, Inc.'s sg&a per share ranks #65 of 206 in the Health Care sector. Increased from $0.60 to $0.75 over the past 2 years.
Based on SEC 10-K filings.
0.75 in FY2024 with a 3-year CAGR of +4.6%.
Increased from $0.60 to $0.75 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#65 of 206 in Health CareTop 31% of 206This company $0.75 Sector average $44.68
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 14.7% year-over-year.
- Ranks #142 out of 206 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.75 | +14.7% |
| FY2023 | $0.65 | +9.3% |
| FY2022 | $0.60 | -8.6% |
| FY2021 | $0.65 | -83.3% |
| FY2020 | $3.92 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026